Esomeprazole Sodium (Akorn, Inc.)
Welcome to the PulseAid listing for the Esomeprazole Sodium drug offered from Akorn, Inc.. This Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Akorn, Inc. |
NON-PROPRIETARY NAME: | Esomeprazole Sodium |
SUBSTANCE NAME: | ESOMEPRAZOLE SODIUM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-03-06 |
END MARKETING DATE: | 0000-00-00 |
Esomeprazole Sodium HUMAN PRESCRIPTION DRUG Details:
Item Description | Esomeprazole Sodium from Akorn, Inc. |
LABELER NAME: | Akorn, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 40(mg/5mL) |
START MARKETING DATE: | 2017-03-06 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 17478-850_8781d2f0-687a-41d0-bdfc-7c05acb0b42c |
PRODUCT NDC: | 17478-850 |
APPLICATION NUMBER: | ANDA207181 |
Other ESOMEPRAZOLE SODIUM Pharmaceutical Manufacturers / Labelers: